1029364-73-5

Basic information

• Product Name: 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
• Synonyms: 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid;6,8-Dimethoxymoxifloxacin;Moxifloxacin related substance B;Moxifloxacin IMpurity B (EP);1-cyclopropyl-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;Moxifloxacin EP Impurity B;Moxifloxacin EP Impurity B Hydrochloride;Moxifloxacin impurity B
• CAS NO: 1029364-73-5
• Molecular Formula: C22H27N3O5
• Molecular Weight: 413
• Mol File: 1029364-73-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 681.0±55.0 °C(Predicted)
• Appearance: /
• Density: 1.356
• Storage Temp.: 2-8°C
• PKA: 6.47±0.50(Predicted)
• CAS DataBase Reference: 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid(1029364-73-5)
• EPA Substance Registry System: 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid(1029364-73-5)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 1029364-73-5(Hazardous Substances Data)

Usage

Description

1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid is a complex organic compound with a unique chemical structure. It belongs to the quinolinecarboxylic acid family and is characterized by its cyclopropyl, dihydro, and dimethoxy functional groups. 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid has potential applications in various fields due to its specific properties and structural features.

Uses

Used in Pharmaceutical Industry:
1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid is used as an active pharmaceutical ingredient (API) for the development of new drugs targeting bacterial infections. Its unique structure and functional groups contribute to its potential antibacterial properties, making it a promising candidate for the treatment of various infections caused by drug-resistant bacteria.
Used in Research and Development:
In the field of research and development, this compound serves as a valuable tool for studying the structure-activity relationships of quinoline-based drugs. It can be used to design and synthesize new analogs with improved pharmacological properties, such as enhanced potency, selectivity, and reduced side effects.
Used in Quality Control and Impurity Profiling:
1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid can be utilized in the quality control and impurity profiling of related drugs, such as Moxifloxacin. By analyzing the presence and concentration of this compound in pharmaceutical products, manufacturers can ensure the safety, efficacy, and quality of the final drug product.